Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / CS
-
Number of holders
-
12
-
Total 13F shares, excl. options
-
178K
-
Shares change
-
+2.36K
-
Total reported value, excl. options
-
$4.63M
-
Value change
-
+$61.7K
-
Number of buys
-
5
-
Number of sells
-
-5
-
Price
-
$26.07
Significant Holders of CHUGAI PHARMA UNSUP ADR - CS (CHGCY) as of Q2 2025
12 filings reported holding CHGCY - CHUGAI PHARMA UNSUP ADR - CS as of Q2 2025.
CHUGAI PHARMA UNSUP ADR - CS (CHGCY) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 178K shares
.
Largest 10 shareholders include Sterling Capital Management LLC (73.3K shares), CONFLUENCE INVESTMENT MANAGEMENT LLC (39.5K shares), RHUMBLINE ADVISERS (28.1K shares), PNC Financial Services Group, Inc. (12.5K shares), GAMMA Investing LLC (11K shares), RIVERBRIDGE PARTNERS LLC (10.8K shares), Brooklyn Investment Group (1.46K shares), HANTZ FINANCIAL SERVICES, INC. (398 shares), THURSTON, SPRINGER, MILLER, HERD & TITAK, INC. (256 shares), and Accent Capital Management, LLC (200 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.